Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: April 18, 2023
Reporting Period: Single event date (April 18, 2023)
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market LLC. The filing reports a specific corporate event under Item 8.01 (Other Events).
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a specific event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
Intellectual Property Milestone: On April 18, 2023, the Company announced it was granted a patent in the United Kingdom. The patent relates to the Company's "Intelligent Fingerprinting Drug Screening System DSR-Plus Cartridge Reader."
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) for full details regarding the patent grant. No forward-looking guidance, financial outlook, or specific risk factors were detailed within the body of this 8-K text.
Unusual Items: None reported beyond the standard patent announcement.
Investor Verification Checklist
- Verify the scope and commercial applicability of the UK patent for the DSR-Plus Cartridge Reader by reviewing the attached Press Release (Exhibit 99.1).
- Confirm the Company's status as an emerging growth company and its implications for financial reporting standards.
- Check subsequent filings for any financial impact or revenue recognition related to this intellectual property.